SBI Life Insurance Company Limited share price
NSE: SBILIFE · ISIN INE123W01016
Key numbers
- Market cap
- ₹ 1,74,793 Cr
- Current price
- ₹ 1,742.00
- 52-week high / low
- ₹ 2,132 / 1,653
- Stock P/E
- 67.1
- Book value
- ₹ 200.7
- Dividend yield
- 0.15%
- ROCE
- 14.1%
- ROE
- 13.7%
- Debt to equity
- -
- Sales growth (3 yrs)
- 11.1%
- Profit growth (3 yrs)
- 12.8%
- 1-year return
- -4.1%
About SBI Life Insurance Company Limited
SBI Life Insurance Company Limited operates as a life insurance company in India. The company's life insurance business comprises individual and group life insurance products, including participating, non-participating, pension, group gratuity, group leave encashment, group superannuation, group annuity, unit-linked and variable insurance products, health, and micro insurance. It also provides accident and disability benefits, level terms, and critical illness insurance products. In addition, the company offers online life insurance, money back income, terms, protection, savings, child plan, wealth, and retirement plans; and corporate solutions, group loan protection, and group micro insurance plans. It provides its products through a multi-channel distribution network comprising individual agents, brokers, corporate agents, bancassurance partners, and certified insurance facilitators, as well as through various partner branches. The company was incorporated in 2000 and is based in Mumbai, India. SBI Life Insurance Company Limited is a subsidiary of State Bank of India.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 23,062 | 39,013 | 46,110 | 4,095 | 46,350 |
| Operating profit | 841 | 611 | 598 | 816 | 746 |
| Net profit | 814 | 594 | 577 | 805 | 725 |
| EPS (₹) | 8.12 | 5.93 | 5.75 | 8.02 | 7.23 |
Concall summary (2026-07-30)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- Against this backdrop, SBI Life continued its growth trajectory from FY 2026 into the first quarter of FY 2027, delivering a 14% increase in Individual Rated Premium, supported by a favorable shift in product mix.
- ULIP stands at INR24.5 billion, contributing 61% vis-a-vis 65% in Q1 FY 2026.
Growth & demand
- Individual Rated Premium stands at INR39.7 billion with a year -on-year growth of 14%, while retaining our leadership position with a 22.2% private market share and a 15.2% total market share.
- The pure protection category registered a strong growth of 41% on Individual APE basis, reflecting rising awareness and demand for comprehensive financial protection , while the individual sum a ssured in the Protection segment grew by 40%.
Margins & costs
- VoNB margin stands at 26.2% for the period ended June 30, 2026.
- We have sustained a healthy margin of 26.2% for the quarter ended 30th June 2026.
Capex & expansion
- All product segments recorded growth on an Individual Rated Premium basis and all key distribution channels achieved double -digit expansion.
- And what we keep mentioning that our expenses and the commission ratio are even on lower side.
Risks & challenges
- Subhendu Bal - President and Chief Risk Officer Mr.
- Second, individual protection growth, that seems a little bit softer.
Peers in Insurance - Life
Data for information only, not investment advice. Prices end of day.